Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Gains from Sales and Divestitures (2020 - 2025)

Historic Gains from Sales and Divestitures for Exponent (EXPO) over the last 9 years, with Q1 2025 value amounting to $266859.0.

  • Exponent's Gains from Sales and Divestitures rose 738.23% to $266859.0 in Q1 2025 from the same period last year, while for Jan 2025 it was $266859.0, marking a year-over-year increase of 738.23%. This contributed to the annual value of $266859.0 for FY2025, which is 738.23% up from last year.
  • According to the latest figures from Q1 2025, Exponent's Gains from Sales and Divestitures is $266859.0, which was up 738.23% from $248513.0 recorded in Q4 2023.
  • Over the past 5 years, Exponent's Gains from Sales and Divestitures peaked at $425983.0 during Q1 2021, and registered a low of $248513.0 during Q4 2023.
  • In the last 4 years, Exponent's Gains from Sales and Divestitures had a median value of $313072.0 in 2022 and averaged $315904.4.
  • In the last 5 years, Exponent's Gains from Sales and Divestitures plummeted by 2368.36% in 2021 and then skyrocketed by 738.23% in 2025.
  • Exponent's Gains from Sales and Divestitures (Quarter) stood at $325095.0 in 2021, then fell by 3.7% to $313072.0 in 2022, then dropped by 20.62% to $248513.0 in 2023, then grew by 7.38% to $266859.0 in 2025.
  • Its Gains from Sales and Divestitures was $266859.0 in Q1 2025, compared to $248513.0 in Q4 2023 and $313072.0 in Q4 2022.